Home > Financial Ratios > SAMRAT PHARMACHEM

SAMRAT PHARMACHEM
EV/Core EBITDA

    Back to All Ratios
SAMRAT PHARMACHEM is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for SAMRAT PHARMACHEM
Please provide your vote to see the results

SAMRAT PHARMACHEM Last 5 Year EV/Core EBITDA History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 9.4926.404.985.735.29

What is the latest EV/Core EBITDA ratio of SAMRAT PHARMACHEM ?

The latest EV/Core EBITDA ratio of SAMRAT PHARMACHEM is 9.49 based on Mar2025 Standalone results.
Year EV/Core EBITDA
Mar20259.49
Mar202426.40
Mar20234.98
Mar20225.73
Mar20215.29

How is EV/Core EBITDA of SAMRAT PHARMACHEM Trending?

Years EV/Core EBITDA % Change
Mar2025 9.49
-64.05
Mar2024 26.4
430.12
Mar2023 4.98
-13.09
Mar2022 5.73
8.32
Mar2021 5.29 -

Other Financial Ratios of SAMRAT PHARMACHEM


Compare EV/Core EBITDA ratio of peers of SAMRAT PHARMACHEM

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SAMRAT PHARMACHEM ₹64.9 Cr -1.5% -2% -41.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹451,075.0 Cr 0.4% 10.8% 10.5% Stock Analytics
DIVIS LABORATORIES ₹179,486.0 Cr 0.7% 9.5% 16.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹149,124.0 Cr -2.5% 6% 36.2% Stock Analytics
CIPLA ₹115,641.0 Cr 9.7% 16.7% -4.9% Stock Analytics
DR REDDYS LABORATORIES ₹111,589.0 Cr 4.5% 9.7% 9% Stock Analytics


SAMRAT PHARMACHEM Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SAMRAT PHARMACHEM

-1.5%

-2%

-41.5%

SENSEX

-2.7%

-2.1%

-5.3%


You may also like the below Video Courses